ALKS Alkermes plc.

8-K Current Report

Filed: February 25, 2026

Health Care

Pharmaceutical Preparations

Alkermes plc. (ALKS) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 2025 and full-year 2025 earnings announced Feb 25, 2026 — details in Exhibit 99.1 press release
• 2026 financial guidance also disclosed — forward outlook in same press release and investor presentation (Exhibit 99.2)

+1 more insights

Other Alkermes plc. 8-K Filings

8-K Feb 25, 2026

Get deeper insights on Alkermes plc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.